Zydus gets USFDA nod for seizure, migraine drug

Zydus Cadila has more than 170 approvals and has so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news

Related Links:

This study investigated differences between episodic and chronic cluster headache with a focus on family history, traumatic history, and change in phenotype. Do these factors differ between subtypes?Headache
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
A 43 ‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in rena l function, no such improvement was seen in patient. AbstractA 43 ‐year‐old man who was treated with interferon‐beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapher...
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research
AbstractEptinezumab is a humanized mAb that targets calcitonin gene ‐related peptide and is under regulatory review for the prevention of episodic and chronic migraine (EM, CM). It is important to determine whether exposures achieved with intravenous (IV) administration of eptinezumab achieve desired pharmacologic effects. Population pharmacokinetics, including do se‐ and exposure‐response analyses, were performed using patient‐level data from the eptinezumab clinical trial program with IV doses ranging from 10 to 1000 mg in pharmacokinetic analyses or 10 to 300 mg in phase 2/3 clinical studies in patient...
Source: Pharmacology Research and Perspectives - Category: Drugs & Pharmacology Authors: Tags: ORIGINAL ARTICLE Source Type: research
On her run, she finished a six-mile loop with no trouble, but she felt a little off: a bit of chest tightness, a headache. Was this coronavirus?
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Tests (Medical) Hospitals Coughs Doctors United States Source Type: news
(HAMBURG, Pa.) — The spring breezes of 2020 are carrying more than just tree pollen. There’s a whiff of paranoia in the air. For millions of seasonal allergy sufferers, the annual onset of watery eyes and scratchy throats is bumping up against the global spread of a new virus that produces its own constellation of respiratory symptoms. Forecasters are predicting a brutal spring allergy season for swaths of the U.S. at the same time that COVID-19 cases are rising dramatically. That’s causing angst for people who never have had to particularly worry about their hay fever, other than to stock up on antihista...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 News Desk wire Source Type: news
Bright Machines, a smart manufacturing company based in San Francisco, offers automation solutions for assembly and inspection of dozens of products, including for the medical device industry. Medgadget recently featured an interview with Jesse Lehga...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Public Health Source Type: blogs
Review what you need to know regarding the three calcitonin CGRP antagonists which were recently FDA approved for prophylactic treatment of migraine.U.S. Pharmacist
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pharmacist Journal Article Source Type: news
“Headaches aren’t welcome here” — that’s the sign you have hanging on your brain’s front door, but the pain is barging right in. You can chalk it up to stress from world events or something you ate or drank, and you might be right. But there are a number of common triggers for migraines, tension headaches, or cluster headaches. The faster you identify them, the quicker you can boot headache pain off the property. What are the triggers for your headaches? Take note of your circumstances when a headache starts. Keep a diary to track the day, time, symptoms, and circumstances surrounding th...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Headache Health Men's Health Women's Health Source Type: blogs
AIMOVIG is a drug used for the preventive treatment of migraine in adults.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news
PMID: 32219862 [PubMed - as supplied by publisher]
Source: Headache - Category: Neurology Authors: Tags: Headache Source Type: research
More News: Biotechnology | Headache | Migraine | New Drug Applications | Pharmaceuticals